Stocks
Goldman-Backed Attovia Raises $289 Million in Top-Priced US IPO
Attovia Therapeutics, an early-stage biotech firm backed by Goldman Sachs, successfully raised $289 million in its US IPO, pricing at the top...
Attovia Therapeutics, an early-stage biotech firm backed by Goldman Sachs, successfully raised $289 million in its US IPO, pricing at the top...